Related Experiment Video
Updated: May 16, 2026

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
MicroRNA miR-34b/c enhances cellular radiosensitivity of malignant pleural mesothelioma cells
Yuho Maki1, Hiroaki Asano, Shinichi Toyooka
1Department of Thoracic Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan.
Background:
We previously reported that epigenetic silencing of microRNA-34b/c (miR-34b/c) plays an important role in the pathogenesis of malignant pleural mesothelioma (MPM). We examined the impact of miR-34b/c restoration on the radiosensitivity of MPM cells.
Materials And Methods:
We established stable miR-34b/c and scramble transfectants of two MPM cell lines, H2052 and H28. We examined these transfectants by clonogenic survival assay, phosphorylated histone H2AX (γH2AX) foci assay, cell-cycle analysis, and western blotting.
Results:
The clonogenic survival assay revealed that miR-34b/c radiosensitized MPM cells. γH2AX foci assay showed that DNA double-strand break repair was delayed in miR-34b/c transfectants. The proportion of sub-G(1) phase cells was increased in miR-34b/c transfectants after irradiation. miR-34b/c inhibited expression of cyclin-D1, cyclin-dependent kinase 4/6, B-cell lymphoma-2 (BCL-2) and increased cleaved poly (ADP-ribose) polymerase (cPARP) and cleaved caspase-3 after irradiation.
Conclusion:
Our results indicate that miR-34b/c enhances radiosensitivity by promoting radiation-induced apoptosis and suggested that miR-34b/c might be a useful therapeutic molecule to enhance radiotherapy in MPM.
Insights
Restoring microRNA-34b/c (miR-34b/c) in malignant pleural mesothelioma (MPM) cells enhances radiosensitivity. This microRNA promotes apoptosis and delays DNA repair, suggesting its therapeutic potential in MPM radiotherapy.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Epigenetic silencing of microRNA-34b/c (miR-34b/c) is implicated in malignant pleural mesothelioma (MPM) pathogenesis.
- Understanding miR-34b/c's role is crucial for developing novel MPM therapies.
Purpose of the Study:
- To investigate the effect of restoring miR-34b/c on the radiosensitivity of MPM cells.
- To elucidate the molecular mechanisms underlying miR-34b/c's impact on radiation response.
Main Methods:
- Established stable miR-34b/c transfectants in H2052 and H28 MPM cell lines.
- Assessed radiosensitivity using clonogenic survival and γH2AX foci assays.
- Analyzed cell cycle progression and protein expression via Western blotting.
Main Results:
- miR-34b/c restoration significantly radiosensitized MPM cells.
- Delayed DNA double-strand break repair and increased sub-G1 phase cells observed in miR-34b/c transfectants post-irradiation.
- miR-34b/c inhibited cell cycle regulators (cyclin-D1, CDK4/6) and apoptosis inhibitors (BCL-2), while promoting apoptosis markers (cleaved PARP, cleaved caspase-3).
Conclusions:
- miR-34b/c enhances MPM radiosensitivity by promoting radiation-induced apoptosis.
- miR-34b/c represents a potential therapeutic target to improve radiotherapy efficacy in MPM.
Related Concept Videos
MicroRNAs
MicroRNAs
Abnormal Proliferation

